CREO — Creo Medical Share News
0.000.00%
- £46.40m
- £30.10m
- £4.00m
- 54
- 63
- 27
- 43
REG - Creo Medical Group - Unaudited results for the six months ended 30 June
AnnouncementREG - Creo Medical Group M&G PLC - Holding(s) in Company
AnnouncementREG - Creo Medical Group - Notice of Results
AnnouncementREG - Creo Medical Group - Director/PDMR Share Dealing
AnnouncementRCS - Creo Medical Group - Speedboat® patient testimonial
AnnouncementREG - Creo Medical Group - Award of Shares under SIP and Director Dealings
AnnouncementREG - Creo Medical Group - H1’25 Trading Update
AnnouncementRCS - Creo Medical Group - MicroBlate™ Flex begins lung tumour clinical study
AnnouncementREG - Creo Medical Group - PDMR Options Revision
AnnouncementREG - Creo Medical Group - Change of Nominated Adviser
AnnouncementREG - Creo Medical Group - Result of AGM
AnnouncementREG - Creo Medical Group - AGM Statement and Directorate Changes
AnnouncementRCS - Creo Medical Group - U.S. FDA clearance for SpydrBlade™ Flex
AnnouncementREG - Creo Medical Group - Director/PDMR Shareholding
AnnouncementREG - Creo Medical Group - Posting of AR&R and Notice of AGM
AnnouncementREG - Creo Medical Group - US Reimbursement milestone for Speedboat procedure
AnnouncementREG - Creo Medical Group M&G PLC - Holding(s) in Company
AnnouncementREG - Creo Medical Group M&G PLC - Holding(s) in Company
AnnouncementREG - Creo Medical Group - Directorate changes
Announcement